pharmaphorum26d
GSK welcomes Brexit transition deal, but wants more 'precision' on final relationship
But we are also looking forward to more precision on the details of the end-stage of the relationship.” GSK recently revealed that it is already spending £50 m a year on its Brexit planning ...
Business Insider27d
Cognition Therapeutics’ VP of Research Co-hosting Precision Medicine Workshop at the Neuroimmunology Drug Development Summit
The workshop, titled “Patient Stratification for Precision Medicine in Neuroscience: How Can We Ensure the Right Patients are Enrolled on the Right Drugs to Treat Their Specific Disease ...
Business Standard27d
GSK Pharma hits 3-month high in weak market; surges 31% in 7 days
The stock of GlaxoSmithKline Pharmaceuticals (GSK Pharma) hit a three-month high of ₹2,640 a share as it surged 5 per cent on Monday before closing at ₹2,638. During the past seven trading days, the ...
Investing27d
GSK acquires IDRx for precision cancer therapies
The acquisition aligns with GSK's strategy to bolster its oncology portfolio, particularly in precision medicines for cancer. IDRX-42 has received Fast Track designation by the U.S. FDA for the ...